ArticleScientific reports2017

Sorafenib suppresses extrahepatic metastasis de novo in hepatocellular carcinoma through inhibition of mesenchymal cancer stem cells characterized by the expression of CD90.

Mariko Yoshida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.